Journal of the American Society of Hypertension
Volume 1, Issue 6 , Pages 414-422, November 2007

Insulin’s actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease

  • Crystal A. Gadegbeku, MD

      Affiliations

    • Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    • Corresponding Author InformationCorresponding author: Crystal A. Gadegbeku, MD, University of Michigan Health System, Department of Medicine, Division of Nephrology, 310 Simpson Memorial Institute, 102 Observatory Road, Ann Arbor, Michigan 48109. Tel: 734-615-3994; fax: 734-615-4887.
  • ,
  • Arachelvi Dhandayuthapani, MD

      Affiliations

    • Internal Medicine and Nephrology, Private Practice, Athens, Georgia, USA
  • ,
  • Timothy P. Taylor, MSRD

      Affiliations

    • Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
  • ,
  • Zakarea Shrayyef, MD

      Affiliations

    • Department of Medicine and Physiology, University of Rochester, Rochester, New York, USA
  • ,
  • John Gerich, MD

      Affiliations

    • Department of Medicine and Physiology, University of Rochester, Rochester, New York, USA
  • ,
  • W. Timothy Garvey, MD

      Affiliations

    • Department of Nutrition Sciences, University of Alabama, Tuscaloosa, Alabama, USA
  • ,
  • Brent M. Egan, MD

      Affiliations

    • Department of Medicine and Pharmacology, Medical University of South Carolina, Charleston, South Carolina, USA

Received 14 February 2007; accepted 29 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by National Institutes of Health RO1-HL58794 which included a minority supplement, K23 RR15542, K24 HL04290, General Clinical Research Center grants M01 RR01070 (Medical University of South Carolina) and 5 M01 RR 00044 (University of Rochester) from the Division of Research Resources, and research funds from the Paul Teschan Research Fund of Dialysis Clinics, Inc.

PII: S1933-1711(07)00125-8

doi:10.1016/j.jash.2007.05.004

Journal of the American Society of Hypertension
Volume 1, Issue 6 , Pages 414-422, November 2007